Summary of Purpose
To assess reliably the effects on mortality and major morbidity of cholesterol-lowering therapy and of antioxidant vitamin supplementation in a wide range of different categories of high-risk patients.Read More →
The following dates are available for this trial. Trial information last updated on 13 May 2003.
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- UK Medical Research Council, British Heart Foundation, Merck Sharp & Dohme, and Hoffman-LaRoche
Randomized 2x2 study design, with 20536 patients, including over 3000 with TIA, and nearly 7000 with minor ischemic stroke or other peripheral vascular disease.